533 related articles for article (PubMed ID: 12202509)
1. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
Moore JE; McMullen TC; Campbell IL; Rohan R; Kaji Y; Afshari NA; Usui T; Archer DB; Adamis AP
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2905-15. PubMed ID: 12202509
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium.
Pauklin M; Steuhl KP; Meller D
Ophthalmology; 2009 Jun; 116(6):1048-56. PubMed ID: 19394701
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization.
Zhu SN; Dana MR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1427-34. PubMed ID: 10359324
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline inhibition of interleukin-1 in the corneal epithelium.
Solomon A; Rosenblatt M; Li DQ; Liu Z; Monroy D; Ji Z; Lokeshwar BL; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2544-57. PubMed ID: 10937565
[TBL] [Abstract][Full Text] [Related]
5. Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte SU; Joussen AM; von Recum HA; Poulaki V; Moromizato Y; Yuan J; D'Amato RJ; Kuo C; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1975-9. PubMed ID: 11481260
[TBL] [Abstract][Full Text] [Related]
6. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
Philipp W; Speicher L; Humpel C
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
[TBL] [Abstract][Full Text] [Related]
8. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein.
Biswas PS; Banerjee K; Zheng M; Rouse BT
J Leukoc Biol; 2004 Oct; 76(4):868-75. PubMed ID: 15258192
[TBL] [Abstract][Full Text] [Related]
9. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells.
Narayanan S; Glasser A; Hu YS; McDermott AM
Exp Eye Res; 2005 Feb; 80(2):175-83. PubMed ID: 15670796
[TBL] [Abstract][Full Text] [Related]
10. The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy.
Okada N; Fukagawa K; Takano Y; Dogru M; Tsubota K; Fujishima H; Matsumoto K; Nakajima T; Saito H
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4512-8. PubMed ID: 16303942
[TBL] [Abstract][Full Text] [Related]
11. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
12. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
[TBL] [Abstract][Full Text] [Related]
13. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
15. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
18. Cytokine modulation of human corneal epithelial cell ICAM-1 (CD54) expression.
Yannariello-brown J; Hallberg CK; Häberle H; Brysk MM; Jiang Z; Patel JA; Ernst PB; Trocme SD
Exp Eye Res; 1998 Oct; 67(4):383-93. PubMed ID: 9820785
[TBL] [Abstract][Full Text] [Related]
19. [Effects of IL-1 receptor antagonist on the level of cytokine in the rat corneal grafts and aqueous humor after corneal transplantation].
Zhang WH; Zhai CB; Pan ZQ; Wu YY
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):587-91. PubMed ID: 14766071
[TBL] [Abstract][Full Text] [Related]
20. The role of integrin alpha5beta1 in the regulation of corneal neovascularization.
Muether PS; Dell S; Kociok N; Zahn G; Stragies R; Vossmeyer D; Joussen AM
Exp Eye Res; 2007 Sep; 85(3):356-65. PubMed ID: 17659277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
